NanJing Pharmaceutical Co Ltd
SSE:600713
NanJing Pharmaceutical Co Ltd
Common Shares Outstanding
NanJing Pharmaceutical Co Ltd
Common Shares Outstanding Peer Comparison
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
NanJing Pharmaceutical Co Ltd
SSE:600713
|
Common Shares Outstanding
¥1.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
6%
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Common Shares Outstanding
¥3.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Common Shares Outstanding
¥3.7B
|
CAGR 3-Years
9%
|
CAGR 5-Years
5%
|
CAGR 10-Years
3%
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Common Shares Outstanding
¥3.9B
|
CAGR 3-Years
28%
|
CAGR 5-Years
16%
|
CAGR 10-Years
9%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Common Shares Outstanding
¥754.5m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
5%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Common Shares Outstanding
¥1.7B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
See Also
What is NanJing Pharmaceutical Co Ltd's Common Shares Outstanding?
Common Shares Outstanding
1.3B
CNY
Based on the financial report for Mar 31, 2024, NanJing Pharmaceutical Co Ltd's Common Shares Outstanding amounts to 1.3B CNY.
What is NanJing Pharmaceutical Co Ltd's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
6%
Over the last year, the Common Shares Outstanding growth was 0%. The average annual Common Shares Outstanding growth rates for NanJing Pharmaceutical Co Ltd have been 7% over the past three years , 4% over the past five years , and 6% over the past ten years .